Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532)
Monica Montopoli, Sara Zumerle, Roberto Vettor, Massimo Rugge, Manuel Zorzi, Carlo V. Catapano, Giuseppina M. Carbone, Andrea Cavalli, Francesco Pagano, Eugenio Ragazzi, T. Prayer-Galetti, Andrea Alimonti
Topics & Concepts
MedicineProstate cancerAndrogen deprivation therapyOncologyPopulationCancerInternal medicineEnvironmental healthProstate Cancer Treatment and ResearchCOVID-19 and healthcare impactsCOVID-19 Clinical Research Studies